INCYTE CORPORATION Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
INCYTE CORPORATION (INCY) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 10.42 million shares for the 3-month period ending 2014-09-30, per its 10-Q filed 2015-11-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2015-11-03
- INCYTE CORPORATION incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2014-09-30 was 10.42M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month |
|---|---|
| 2014-09-30 | 10.42M shares 10-Q · filed 2015-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |